Image

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

AI helps predict Parkinson's risk in REM sleep disorder patients.

Recruiting
18 years and older
All
Phase N/A
**Artificial Intelligence in Molecular Imaging Study** This study is looking at people with REM sleep behavior disorder (RBD), which is when you act out your dreams during sleep. They want to see if these people might develop Parkinson's disease (PD), dementia with Lewy bodies (DLB), or multiple system atrophy (MSA) in the future. **Artificial intelligence (AI)** will be used to check brain images and see who might be at risk. **Key Points:** - You will need to visit for clinical evaluation and have 2 imaging tests done. - You must have RBD but not already have Parkinson's or other brain disorders. - No signs of parkinsonism, narcolepsy, or moderate to severe sleep apnea are allowed. The study requires you to give written consent and you must not have any existing neurological issues. This research helps find ways to predict and possibly prevent these serious diseases using advanced technology.
Study details
    Parkinson Disease
    REM Sleep Behavior Disorder
    Dementia
    Lewy Body

NCT06629207

Insel Gruppe AG, University Hospital Bern

17 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.